Alison Strutt
CFO
Alison has extensive strategic, transactional and operational experience. She formerly held a number of senior finance roles at GlaxoSmithKline, including as Chief of Staff to the Chief Finance Officer, where she was responsible for transforming GSK’s financial reporting processes and organisation as well as leading local completions of the global Novartis transaction. Alison also served as CFO of GSK’s drug discovery group, where she established the Tres Cantos Open Lab and Catalyst Science Park at GSK’s UK R&D site. Prior to joining GSK, Alison led the UK M&A life sciences team at Deloitte in London. Alison holds a Ph.D. in chemistry and physical chemistry from the University of Wales, Cardiff and is a Fellow of the Institute of Chartered Accountants for England and Wales.